Literature DB >> 21107775

Micronization of a soft material: air-jet and micro-ball milling.

Imran Y Saleem1, Hugh D C Smyth.   

Abstract

The air-jet and ball-mill are frequently used in fine micronization of active pharmaceutical ingredients to the order of 1-5 microm, which is important for increasing dissolution rates, and also for pulmonary delivery. In this study, we investigated the ability of air-jet and ball-mill to achieve adequate micronization on the lab scale using a model soft material, Pluronic F-68. Material mechanical properties were characterized using the nanometer 600. Pluronic F-68 was ball-milled in a micro-mill at different material weights and durations in liquid nitrogen vapor. In comparison, a lab scale air-jet mill was used at various milling parameters according to a full factorial design, where the response factors were particle yield and particle size distribution, which was analyzed using laser diffraction and scanning electron microscopy. The yield achieved with the micro-ball mill was 100% but was ~80% for the air-jet mill, which reduced the size of Pluronic F-68 from 70 microm to sizes ranging between 23-39 microm median diameters. Ball milling produced particles less than 10 microm after 15 min. Although air-jet milling proved capable of particle size reduction of the relatively soft material Pluronic F-68, limitations to the lower size range achievable were observed. The feed rate of the material into the air jet mill was a significant factor and slower feed rates lead to smaller sizes by allowing more time for particle collisions and subsequent particle breakage to occur. Micro-ball milling under cold condition was more successful at achieving a lower range particle size reduction of soft materials.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21107775      PMCID: PMC3011070          DOI: 10.1208/s12249-010-9542-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  21 in total

1.  Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing.

Authors:  M Irngartinger; V Camuglia; M Damm; J Goede; H W Frijlink
Journal:  Eur J Pharm Biopharm       Date:  2004-07       Impact factor: 5.571

2.  Influence of nanomechanical crystal properties on the comminution process of particulate solids in spiral jet mills.

Authors:  Sascha Zügner; Karin Marquardt; Ingfried Zimmermann
Journal:  Eur J Pharm Biopharm       Date:  2005-10-03       Impact factor: 5.571

Review 3.  Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery.

Authors:  Sunday A Shoyele; Alex Slowey
Journal:  Int J Pharm       Date:  2006-03-24       Impact factor: 5.875

4.  Formation and physical stability of the amorphous phase of ranitidine hydrochloride polymorphs prepared by cryo-milling.

Authors:  Norman Chieng; Thomas Rades; Dorothy Saville
Journal:  Eur J Pharm Biopharm       Date:  2007-09-14       Impact factor: 5.571

5.  Theoretical relationship of lung deposition to the fine particle fraction of inhalation aerosols.

Authors:  A J Hickey; T B Martonen; Y Yang
Journal:  Pharm Acta Helv       Date:  1996-08

Review 6.  Polymeric nanostructures for drug delivery applications based on Pluronic copolymer systems.

Authors:  X Y Xiong; K C Tam; L H Gan
Journal:  J Nanosci Nanotechnol       Date:  2006 Sep-Oct

7.  Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation.

Authors:  X M Zeng; G P Martin; S K Tee; A A Ghoush; C Marriott
Journal:  Int J Pharm       Date:  1999-05-25       Impact factor: 5.875

8.  Effect of pluronic P85 on ATPase activity of drug efflux transporters.

Authors:  Elena V Batrakova; Shu Li; Yili Li; Valery Yu Alakhov; Alexander V Kabanov
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

9.  Formulation of a dry powder influenza vaccine for nasal delivery.

Authors:  Robert J Garmise; Kevin Mar; Timothy M Crowder; C Robin Hwang; Matthew Ferriter; Juan Huang; John A Mikszta; Vincent J Sullivan; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2006-03-10       Impact factor: 3.246

10.  Characterization of pharmaceutical solids by scanning probe microscopy.

Authors:  Xiangmin Liao; Timothy Scott Wiedmann
Journal:  J Pharm Sci       Date:  2004-09       Impact factor: 3.534

View more
  3 in total

1.  In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization.

Authors:  Yi-Bo Wang; Alan B Watts; Jay I Peters; Sha Liu; Ayesha Batra; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2014-05-14       Impact factor: 3.246

Review 2.  Process optimization and particle engineering of micronized drug powders via milling.

Authors:  A Brunaugh; H D C Smyth
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

3.  Formulation and characterization of a plasma sterilized, pharmaceutical grade chitosan powder.

Authors:  Andrew R Crofton; Samuel M Hudson; Kristy Howard; Tyler Pender; Abdelrahman Abdelgawad; Daniel Wolski; Wolff M Kirsch
Journal:  Carbohydr Polym       Date:  2016-03-06       Impact factor: 9.381

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.